Back to Search
Start Over
Mutations associated with a 17-gene leukemia stem cell score and the score’s prognostic relevance in the context of the European LeukemiaNet classification of acute myeloid leukemia
- Source :
- Haematologica
- Publication Year :
- 2020
- Publisher :
- Ferrata Storti Foundation, 2020.
-
Abstract
- Leukemia stem cells (LSC) are more resistant to standard chemotherapy and their persistence during remission can cause relapse, which is still one of the major clinical challenges in the treatment of acute myeloid leukemia (AML). A better understanding of the mutational patterns and the prognostic impact of molecular markers associated with stemness could lead to better clinical management and improve patients' outcomes. We applied a previously described 17-gene expression score comprising genes differently expressed between LSC and leukemic bulk blasts, for 934 adult patients with de novo AML, and studied associations of the 17-gene LSC score with clinical data and mutation status of 81 genes recurrently mutated in cancer and leukemia. We found that patients with a high 17-gene score were older and had more mutations. The 17-gene score was found to have a prognostic impact in both younger (aged
- Subjects :
- Oncology
Acute Myeloid Leukemia
medicine.medical_specialty
medicine.medical_treatment
Context (language use)
Risk Assessment
03 medical and health sciences
European LeukemiaNet
0302 clinical medicine
Internal medicine
Medicine
Humans
Gene
Chemotherapy
business.industry
Stem Cells
Myeloid leukemia
Cancer
Hematology
medicine.disease
Prognosis
3. Good health
Leukemia
Leukemia, Myeloid, Acute
Mutation
Aticle
Stem cell
business
Transcriptome
030215 immunology
Subjects
Details
- Language :
- English
- ISSN :
- 15928721 and 03906078
- Volume :
- 105
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- Haematologica
- Accession number :
- edsair.doi.dedup.....e5d0d215b955cfbc3d2d34c7ab91c6bd